StockDrifts LogoStockDrifts

Jinyang Pharmaceutical 007370

Company
진양제약Jinyang Pharmaceutical
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-05-29

Jinyang Pharmaceutical (007370) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Jinyang Pharmaceutical is dated 2025-06-16; the most recent is 2026-05-29.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-05-29SELL증여
최윤환
Yunhwan Choi
Chairman-100.0K₩4,270+2.3%₩427M ($297K)
2026-05-29SELL증여
최윤환
Yunhwan Choi
Chairman-100.0K₩4,270+2.3%₩427M ($297K)
2026-05-12SELL장외매도
최윤환
Yunhwan Choi
Chairman-10.0K₩4,625+2.5%₩46M ($32K)
2026-05-11SELL장외매도
최윤환
Yunhwan Choi
Chairman-210.0K₩4,680+3.6%₩983M ($683K)
2025-07-02BUY장외매수
최윤환
Yunhwan Choi
CEO Chairman320.0K₩6,370-19.1%₩2.0B ($1.4M)
2025-06-16BUYCB인수
최윤환
Yunhwan Choi
CEO Chairman171.7K₩6,410-19.7%₩1.1B ($764K)

Frequently asked questions

Who has been buying Jinyang Pharmaceutical stock?
0 distinct insiders have filed 0 disclosed insider purchases in Jinyang Pharmaceutical (007370), most recently on 2026-05-29. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Jinyang Pharmaceutical have?
Jinyang Pharmaceutical has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-06-16 to 2026-05-29.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.